BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shao S, Cao H, Wang Z, Zhou D, Wu C, Wang S, Xia D, Zhang D. CHD4/NuRD complex regulates complement gene expression and correlates with CD8 T cell infiltration in human hepatocellular carcinoma. Clin Epigenetics 2020;12:31. [PMID: 32070428 DOI: 10.1186/s13148-020-00827-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Lv X, Wei B, Gong X, Chen L. CHD4 mediates SOX2 transcription through TRPS1 in luminal breast cancer. Cell Signal 2022;100:110464. [PMID: 36075559 DOI: 10.1016/j.cellsig.2022.110464] [Reference Citation Analysis]
2 Jia M, Zou X, Yin S, Tian W, Zhao Y, Wang H, Xu G, Cai W, Shao Q. CHD4 orchestrates the symphony of T and B lymphocytes development and a good mediator in preventing from autoimmune disease. Immunity Inflam & Disease 2022;10. [DOI: 10.1002/iid3.644] [Reference Citation Analysis]
3 Reid XJ, Low JK, Mackay JP. A NuRD for all seasons. Trends in Biochemical Sciences 2022. [DOI: 10.1016/j.tibs.2022.06.002] [Reference Citation Analysis]
4 Zhou H, Jiang L, Wang G, Su L, Hou L, Xue X. Identification of MCM4 as a Prognostic Marker of Hepatocellular Carcinoma. Biomed Res Int 2021;2021:7479326. [PMID: 34961841 DOI: 10.1155/2021/7479326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Wu C, Xia D, Wang D, Wang S, Sun Z, Xu B, Zhang D. TCOF1 coordinates oncogenic activation and rRNA production and promotes tumorigenesis in HCC. Cancer Sci 2021. [PMID: 34904330 DOI: 10.1111/cas.15242] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Romito I, Porru M, Braghini MR, Pompili L, Panera N, Crudele A, Gnani D, De Stefanis C, Scarsella M, Pomella S, Levi Mortera S, de Billy E, Conti AL, Marzano V, Putignani L, Vinciguerra M, Balsano C, Pastore A, Rota R, Tartaglia M, Leonetti C, Alisi A. Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects. J Exp Clin Cancer Res 2021;40:364. [PMID: 34784956 DOI: 10.1186/s13046-021-02154-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
7 Sun Z, Zhou D, Yang J, Zhang D. Doxorubicin promotes breast cancer cell migration and invasion via DCAF13. FEBS Open Bio 2021. [PMID: 34775691 DOI: 10.1002/2211-5463.13330] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Sonntag R, Penners C, Kohlhepp M, Haas U, Lambertz D, Kroh A, Cramer T, Ticconi F, Costa IG, Tacke F, Gassler N, Trautwein C, Liedtke C. Cyclin E1 in Murine and Human Liver Cancer: A Promising Target for Therapeutic Intervention during Tumour Progression. Cancers (Basel) 2021;13:5680. [PMID: 34830835 DOI: 10.3390/cancers13225680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Liu Y, Liu X, Gu Y, Lu H. A novel RNA binding protein-associated prognostic model to predict overall survival in hepatocellular carcinoma patients. Medicine (Baltimore) 2021;100:e26491. [PMID: 34398005 DOI: 10.1097/MD.0000000000026491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hai R, He L, Shu G, Yin G. Characterization of Histone Deacetylase Mechanisms in Cancer Development. Front Oncol 2021;11:700947. [PMID: 34395273 DOI: 10.3389/fonc.2021.700947] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
11 Torres-Martinez Z, Delgado Y, Ferrer-Acosta Y, Suarez-Arroyo IJ, Joaquín-Ovalle FM, Delinois LJ, Griebenow K. Key genes and drug delivery systems to improve the efficiency of chemotherapy. Cancer Drug Resist 2021;4:163-91. [PMID: 34142021 DOI: 10.20517/cdr.2020.64] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang S, Xia D, Wang X, Cao H, Wu C, Sun Z, Zhang D, Liu H. C/EBPβ regulates the JAK/STAT signaling pathway in triple-negative breast cancer. FEBS Open Bio 2021;11:1250-8. [PMID: 33660927 DOI: 10.1002/2211-5463.13138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Liu X, Wang J. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma. Int Immunopharmacol 2020;88:106887. [PMID: 32799111 DOI: 10.1016/j.intimp.2020.106887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Milazzo G, Mercatelli D, Di Muzio G, Triboli L, De Rosa P, Perini G, Giorgi FM. Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability. Genes (Basel) 2020;11:E556. [PMID: 32429325 DOI: 10.3390/genes11050556] [Cited by in Crossref: 91] [Cited by in F6Publishing: 98] [Article Influence: 45.5] [Reference Citation Analysis]